STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy

Summary

Research identifies estrogen-driven STING reprogramming and neutrophil extracellular trap formation as a mechanism limiting ADC therapy efficacy in a sex-biased manner. The study provides mechanistic insights into sex differences in antibody-based cancer therapy.